{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:04:14Z","timestamp":1792184654516,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.psychres.2008.06.025","type":"journal-article","created":{"date-parts":[[2009,12,30]],"date-time":"2009-12-30T09:13:10Z","timestamp":1262164390000},"page":"260-265","source":"Crossref","is-referenced-by-count":20,"title":["Double-blind comparison of 30 and 60\u00a0mg tranylcypromine daily in patients with panic disorder comorbid with social anxiety disorder"],"prefix":"10.1016","volume":"175","author":[{"given":"Antonio E.","family":"Nardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana L.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre M.","family":"Valen\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael C.","family":"Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre B.","family":"Veras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A.","family":"Mezzasalma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valfrido L.","family":"de-Melo-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gast\u00e3o L.","family":"Soares-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Lucia","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila O.","family":"Grivet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arabella","family":"Rassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio","family":"Versiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2008.06.025_bib1","first-page":"448","article-title":"Calming effects of the monoamine oxidase inhibitors","volume":"11","author":"Arnot","year":"1960","journal-title":"Diseases of the Nervous System"},{"key":"10.1016\/j.psychres.2008.06.025_bib2","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1176\/ps.50.7.945","article-title":"A survey of prescribing practices for monoamine oxidase inhibitors","volume":"50","author":"Balon","year":"1999","journal-title":"Psychiatric Services"},{"issue":"S1","key":"10.1016\/j.psychres.2008.06.025_bib3","first-page":"38","article-title":"Review of the use of the irreversible monoamine oxidase inhibitors (MAOIs) in psychiatry","volume":"11","author":"Bechelli","year":"1989","journal-title":"Current Medical Research Opinions"},{"key":"10.1016\/j.psychres.2008.06.025_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0010-440X(86)90051-9","article-title":"A case of social phobia with avoidant personality disorder treated with MAOI","volume":"27","author":"Deltito","year":"1986","journal-title":"Comprehensive Psychiatry"},{"key":"10.1016\/j.psychres.2008.06.025_bib5","first-page":"321","article-title":"Quality of Life Enjoyment and Satisfation Questionnaire: a new measure","volume":"29","author":"Endicott","year":"1993","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1016\/j.psychres.2008.06.025_bib6","series-title":"Structured Clinical Interview Diagnostic (SCID) for DSM-IV Axis I Disorders \u2014 Clinician Version (SCID-CV)","author":"First","year":"1997"},{"key":"10.1016\/j.psychres.2008.06.025_bib7","series-title":"Comorbidity of Mood and Anxiety Disorders","first-page":"41","article-title":"The influence of classification methods on comorbidity","author":"Frances","year":"1990"},{"key":"10.1016\/j.psychres.2008.06.025_bib8","first-page":"452","article-title":"Three cases of overlap between panic disorder, social phobia, and agoraphobia","volume":"48","author":"Goldstein","year":"1987","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2008.06.025_bib9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-1781(02)00320-7","article-title":"Lifetime comorbidity of antisocial personality disorder and anxiety disorders among adults in the community","volume":"117","author":"Goodwin","year":"2003","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.psychres.2008.06.025_bib10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1176\/appi.ajp.157.4.493","article-title":"Neuroanatomical hypothesis of panic disorder, revised","volume":"157","author":"Gorman","year":"2000","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2008.06.025_bib11","doi-asserted-by":"crossref","unstructured":"Guy, W. (Ed.), 1976. ECDEU Assessment Manual for Psychopharmacology, Revised. DHEW Publication. Superintendent of Documents, Government Printing Office, Washington, DC.","DOI":"10.1037\/e591322011-001"},{"key":"10.1016\/j.psychres.2008.06.025_bib12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"British Journal of Medical Psychology"},{"key":"10.1016\/j.psychres.2008.06.025_bib13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.psychres.2008.06.025_bib14","first-page":"947","article-title":"Treatment of panic and phobic disorders","volume":"6","author":"Jann","year":"1987","journal-title":"Clinical Pharmacology"},{"key":"10.1016\/j.psychres.2008.06.025_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00004714-198604000-00006","article-title":"Phenelzine in social phobia","volume":"6","author":"Liebowitz","year":"1986","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.psychres.2008.06.025_bib16","first-page":"242","article-title":"Pharmacotherapy of social phobia: an interim report of a placebo-controlled comparison of phenelzine and atenolol","volume":"49","author":"Liebowitz","year":"1988","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2008.06.025_bib17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archpsyc.1985.01790300097013","article-title":"Social phobia. Review of a neglected anxiety disorder","volume":"42","author":"Liebowitz","year":"1985","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2008.06.025_bib18","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1192\/bjp.160.2.165","article-title":"Panic attacks: a neurochemical overview of models and mechanisms","volume":"160","author":"Nutt","year":"1992","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2008.06.025_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0165-0327(99)00062-2","article-title":"Avoidant personality in social phobia and panic-agoraphobic disorder: a comparison","volume":"54","author":"Perugi","year":"1999","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.psychres.2008.06.025_bib20","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/archpsyc.1990.01810220051006","article-title":"Atypical depression, panic attacks, and response to imipramine and phenelzine: a replication","volume":"47","author":"Quitkin","year":"1990","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2008.06.025_bib21","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1176\/appi.ajp.157.6.1014","article-title":"Is placebo response the same as drug response in panic disorder","volume":"157","author":"Rapaport","year":"2000","journal-title":"American Journal of Psychiatry"},{"issue":"suppl. 1","key":"10.1016\/j.psychres.2008.06.025_bib22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4","article-title":"Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders","volume":"12","author":"Ressler","year":"2000","journal-title":"Depression and Anxiety"},{"key":"10.1016\/j.psychres.2008.06.025_bib23","doi-asserted-by":"crossref","first-page":"023","DOI":"10.1016\/S0140-6736(06)69418-X","article-title":"Panic disorder","volume":"368","author":"Roy-Byrne","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2008.06.025_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/bmj.2.5648.49","article-title":"Treatment of the phobic anxiety state","volume":"3","author":"Sargant","year":"1969","journal-title":"British Medical Journal"},{"key":"10.1016\/j.psychres.2008.06.025_bib25","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1176\/ajp.154.11.1571","article-title":"Multicenter Collaborative Panic Disorder Severity Scale","volume":"154","author":"Shear","year":"1997","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2008.06.025_bib26","series-title":"The Anxiety Disease","author":"Sheehan","year":"1983"},{"key":"10.1016\/j.psychres.2008.06.025_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archpsyc.1980.01780140053006","article-title":"Treatment of endogenous anxiety with phobic, hysterical and hypochondrial symptoms","volume":"37","author":"Sheehan","year":"1980","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2008.06.025_bib28","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00004714-199804000-00005","article-title":"Imipramine in the treatment of social phobia","volume":"18","author":"Simpson","year":"1998","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.psychres.2008.06.025_bib29","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1176\/ajp.147.5.637","article-title":"Major depression in patients with social phobia","volume":"147","author":"Stein","year":"1990","journal-title":"American Journal of Psychiatry"},{"issue":"22 Suppl","key":"10.1016\/j.psychres.2008.06.025_bib30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0022-3956(88)90070-2","article-title":"Monoamine oxidase inhibitors in anxiety disorders","volume":"1","author":"Tyrer","year":"1988","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.psychres.2008.06.025_bib31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF00422146","article-title":"A study of the clinical effects of phenelzine and placebo in the treatment of phobic anxiety","volume":"32","author":"Tyrer","year":"1973","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.psychres.2008.06.025_bib32","series-title":"Treatment of Panic Disorder with Alprazolam, Imipramine, Tranylcypromine or Placebo. Annual Meeting of the American College of Neuropsychopharmacology","first-page":"276","author":"Versiani","year":"1987"},{"key":"10.1016\/j.psychres.2008.06.025_bib33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00004714-198808000-00008","article-title":"Tranylcypromine in social phobia","volume":"8","author":"Versiani","year":"1988","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.psychres.2008.06.025_bib34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1192\/bjp.161.3.353","article-title":"social phobia: a controlled study with moclobemide and phenelzine","volume":"161","author":"Versiani","year":"1992","journal-title":"British Journal of Psychiatry"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178108001947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178108001947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T21:22:05Z","timestamp":1558732925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178108001947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0165178108001947"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2008.06.025","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}